- Efficacy and Safety of Roflumilast in Korean Patients with COPD
-
Lee JS, Hong YK, Park TS, Lee SW, Oh YM, Lee SD
- KMID: 2374125
- Yonsei Med J.
- 2016 Jul;57(4):928-935.
- doi: 10.3349/ymj.2016.57.4.928
PURPOSE: Roflumilast is the only oral phosphodiesterase 4 inhibitor approved to treat chronic obstructive pulmonary disease (COPD) patients [post-bronchodilator forced expiratory volume in 1 second (FEV1) -
- CITED
-
- Close
- SHARE
-
- Close
